Randomized, double-blind, placebo-controlled trial of oromucosal low-dose interferon following prednisone withdrawal for chronic hepatitis B infection in Filipino patients

An official corporate certificate document layout featuring crisp typography, structured margins, and formal signatures, formally recognizing the institutional contributions of the Tropical Disease Foundation, Inc.

For any concerns about Data Privacy.

Data Privacy Officer:
John Phillip C. Ubalde
Email: [email protected]